Assessment of role of auto-HCT as the standard-of-care in transplant-eligible patients with relapsed Diffuse-large-B-cell-lymphoma in partial remission after salvage therapy
Latest Information Update: 30 Sep 2021
At a glance
- Drugs Axicabtagene ciloleucel (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 30 Sep 2021 New trial record
- 27 Sep 2021 Results published in the Blood